Advertisement

Study Assesses Efficacy and Safety of Biosimilar Product for Psoriasis

BI695501 is a biosimilar product for adalimumab. A phase IIIb study compared BI695501 to the reference product adalimumab in patients with moderate-to-severe...

Patient Preferences for Telemedicine Versus In-Person Dermatology Visits

Researchers assessed patient preferences between real-time teledermatology (RTTD) and in-person visits and found that the main concern with teledermatology was the potential...

Dupilumab Appears Safe for Use in Patients Younger Than 5 Years with Atopic Dermatitis

A study found that dupilumab was clinically beneficial in reducing signs and symptoms of atopic dermatitis (AD) in children aged two to...

Pulse Therapy Versus Continuous Therapy for Toenail Onychomycosis

Onychomycosis is a persistent fungal infection of the nails and adjacent skin, manifesting as discoloration, thickening of the nail, and onycholysis. A...
Advertisement